Ads blast Merck on AIDS drug prices in Mexico

Share this article:
Ads blast Merck on AIDS drug prices in Mexico
Ads blast Merck on AIDS drug prices in Mexico
The AIDS Healthcare Foundation launched a print ad aimed at shaming Merck in its own neighborhood for the prices it charges for AIDS drug Stocrin (Sustiva) in Mexico.

The nonprofit, a frequent nemesis of the pharma industry which has previously run ads slamming drug companies for how they price and market their drugs, ran the ad in The Courier News of Somerset County, NJ, near Merck's US corporate headquarters. With the tagline “Shame on Merck,” the ad copy reads in part: “Merck's Stocrin (efavirenz) is the backbone of many standard antiretroviral drug regimens. AIDS advocates question why Stocrin costs approximately $140 USD in Honduras, yet Merck charges $893 USD for Stocrin in Mexico. Advocates and HIV/AIDS patients insist Merck must match its lowest available price of Stocrin in other Latin American countries in Mexico as well.”

The ads, timed to coincide with the 2008 International AIDS conference in Mexico, will also appear in The Hunterdon County Democrat, The Village Voice and The Washington Blade.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.

Five things for Pharma Marketers to Know: Thursday, August 28

Five things for Pharma Marketers to Know: Thursday, ...

Human testing of GSK's Ebola virus starts next week, menopause is a costly healthcare concern, and a small conversation with pharmacists may have a big impact.